Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease

C. N. Randall, D. Strasburger, J. Prozonic, S. N. Morris, A. D. Winkie, G. R. Parker, Danny Cheng, E. M. Fennell, I. Lanham, N. Vakil, J. Huang, H. Cathcart, R. Huang, S. E. Poduslo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Multiple genetic variants may contribute to the risk of developing Alzheimer's disease. We have analyzed polymorphisms in 9 genes to determine whether particular combinations would contribute to this risk. The genes were APOE, LDLr, CST3, CTSD, TNF, BACE1, MAPT, STH, eNOS, and TFCP2. Three risk groups for the disease were identified. Risk group I was younger, was heterozygous for the CST3 (GA), CTSD2936 (AG), TNF -308 (AG) genetic variants. Risk group II was older, was homozygous for the -427 APOE promoter polymorphism (TT), and heterozygous for the MAPT deletion and for the STH variant (QR). Group III had both the youngest and oldest subjects, were heterozygous for the -863 (AC) and -1031 (CT) TNF promoter polymorphisms. All three groups carried the APOE 4 allele and were heterozygous for both BACE1 polymorphisms. The control groups were carriers of the APOE 3 allele and were homozygous for the BACE1 genetic variants.

Original languageEnglish (US)
Pages (from-to)23-28
Number of pages6
JournalNeurochemical Research
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Cluster analysis
Genetic Polymorphisms
Polymorphism
Cluster Analysis
Alzheimer Disease
Genes
Alleles
Control Groups

Keywords

  • Alzheimer's disease
  • Cluster analysis
  • Genetic variants
  • Risk factors

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Randall, C. N., Strasburger, D., Prozonic, J., Morris, S. N., Winkie, A. D., Parker, G. R., ... Poduslo, S. E. (2009). Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease. Neurochemical Research, 34(1), 23-28. https://doi.org/10.1007/s11064-008-9626-8

Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease. / Randall, C. N.; Strasburger, D.; Prozonic, J.; Morris, S. N.; Winkie, A. D.; Parker, G. R.; Cheng, Danny; Fennell, E. M.; Lanham, I.; Vakil, N.; Huang, J.; Cathcart, H.; Huang, R.; Poduslo, S. E.

In: Neurochemical Research, Vol. 34, No. 1, 01.01.2009, p. 23-28.

Research output: Contribution to journalArticle

Randall, CN, Strasburger, D, Prozonic, J, Morris, SN, Winkie, AD, Parker, GR, Cheng, D, Fennell, EM, Lanham, I, Vakil, N, Huang, J, Cathcart, H, Huang, R & Poduslo, SE 2009, 'Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease', Neurochemical Research, vol. 34, no. 1, pp. 23-28. https://doi.org/10.1007/s11064-008-9626-8
Randall CN, Strasburger D, Prozonic J, Morris SN, Winkie AD, Parker GR et al. Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease. Neurochemical Research. 2009 Jan 1;34(1):23-28. https://doi.org/10.1007/s11064-008-9626-8
Randall, C. N. ; Strasburger, D. ; Prozonic, J. ; Morris, S. N. ; Winkie, A. D. ; Parker, G. R. ; Cheng, Danny ; Fennell, E. M. ; Lanham, I. ; Vakil, N. ; Huang, J. ; Cathcart, H. ; Huang, R. ; Poduslo, S. E. / Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease. In: Neurochemical Research. 2009 ; Vol. 34, No. 1. pp. 23-28.
@article{68e8de54c55440519f8fc1ce9293a761,
title = "Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease",
abstract = "Multiple genetic variants may contribute to the risk of developing Alzheimer's disease. We have analyzed polymorphisms in 9 genes to determine whether particular combinations would contribute to this risk. The genes were APOE, LDLr, CST3, CTSD, TNF, BACE1, MAPT, STH, eNOS, and TFCP2. Three risk groups for the disease were identified. Risk group I was younger, was heterozygous for the CST3 (GA), CTSD2936 (AG), TNF -308 (AG) genetic variants. Risk group II was older, was homozygous for the -427 APOE promoter polymorphism (TT), and heterozygous for the MAPT deletion and for the STH variant (QR). Group III had both the youngest and oldest subjects, were heterozygous for the -863 (AC) and -1031 (CT) TNF promoter polymorphisms. All three groups carried the APOE 4 allele and were heterozygous for both BACE1 polymorphisms. The control groups were carriers of the APOE 3 allele and were homozygous for the BACE1 genetic variants.",
keywords = "Alzheimer's disease, Cluster analysis, Genetic variants, Risk factors",
author = "Randall, {C. N.} and D. Strasburger and J. Prozonic and Morris, {S. N.} and Winkie, {A. D.} and Parker, {G. R.} and Danny Cheng and Fennell, {E. M.} and I. Lanham and N. Vakil and J. Huang and H. Cathcart and R. Huang and Poduslo, {S. E.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s11064-008-9626-8",
language = "English (US)",
volume = "34",
pages = "23--28",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Cluster analysis of risk factor genetic polymorphisms in alzheimer's disease

AU - Randall, C. N.

AU - Strasburger, D.

AU - Prozonic, J.

AU - Morris, S. N.

AU - Winkie, A. D.

AU - Parker, G. R.

AU - Cheng, Danny

AU - Fennell, E. M.

AU - Lanham, I.

AU - Vakil, N.

AU - Huang, J.

AU - Cathcart, H.

AU - Huang, R.

AU - Poduslo, S. E.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Multiple genetic variants may contribute to the risk of developing Alzheimer's disease. We have analyzed polymorphisms in 9 genes to determine whether particular combinations would contribute to this risk. The genes were APOE, LDLr, CST3, CTSD, TNF, BACE1, MAPT, STH, eNOS, and TFCP2. Three risk groups for the disease were identified. Risk group I was younger, was heterozygous for the CST3 (GA), CTSD2936 (AG), TNF -308 (AG) genetic variants. Risk group II was older, was homozygous for the -427 APOE promoter polymorphism (TT), and heterozygous for the MAPT deletion and for the STH variant (QR). Group III had both the youngest and oldest subjects, were heterozygous for the -863 (AC) and -1031 (CT) TNF promoter polymorphisms. All three groups carried the APOE 4 allele and were heterozygous for both BACE1 polymorphisms. The control groups were carriers of the APOE 3 allele and were homozygous for the BACE1 genetic variants.

AB - Multiple genetic variants may contribute to the risk of developing Alzheimer's disease. We have analyzed polymorphisms in 9 genes to determine whether particular combinations would contribute to this risk. The genes were APOE, LDLr, CST3, CTSD, TNF, BACE1, MAPT, STH, eNOS, and TFCP2. Three risk groups for the disease were identified. Risk group I was younger, was heterozygous for the CST3 (GA), CTSD2936 (AG), TNF -308 (AG) genetic variants. Risk group II was older, was homozygous for the -427 APOE promoter polymorphism (TT), and heterozygous for the MAPT deletion and for the STH variant (QR). Group III had both the youngest and oldest subjects, were heterozygous for the -863 (AC) and -1031 (CT) TNF promoter polymorphisms. All three groups carried the APOE 4 allele and were heterozygous for both BACE1 polymorphisms. The control groups were carriers of the APOE 3 allele and were homozygous for the BACE1 genetic variants.

KW - Alzheimer's disease

KW - Cluster analysis

KW - Genetic variants

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=58149465729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149465729&partnerID=8YFLogxK

U2 - 10.1007/s11064-008-9626-8

DO - 10.1007/s11064-008-9626-8

M3 - Article

C2 - 18307033

AN - SCOPUS:58149465729

VL - 34

SP - 23

EP - 28

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 1

ER -